| Myelosuppression and "conventional" chemotherapy: what price, what benefit? |
| GP Canellos and GD Demetri |
|
JCO Jan 1 1993: 1–2.
[PDF]
|
 |
| Age and the treatment of breast cancer |
| RD Rubens |
|
JCO Jan 1 1993: 3–4.
[PDF]
|
|
| Karnofsky memorial lecture. Ode to methotrexate |
| JR Bertino |
|
JCO Jan 1 1993: 5–14.
[PDF]
|
|
|
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group |
| |
WP Steward, J Verweij, R Somers, D Spooner, P Kerbrat, M Clavel, D Crowther, J Rouesse, T Tursz, and E Tueni |
| |
JCO Jan 1 1993: 15–21.
[Abstract]
[PDF]
|
|
|
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction |
| |
JA Ajani, JA Roth, MB Ryan, JB Putnam, R Pazdur, B Levin, JU Gutterman, and M McMurtrey |
| |
JCO Jan 1 1993: 22–28.
[Abstract]
[PDF]
|
|
|
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death |
| |
FJ Cummings, R Gray, DC Tormey, TE Davis, H Volk, J Harris, G Falkson, and JM Bennett |
| |
JCO Jan 1 1993: 29–35.
[Abstract]
[PDF]
|
|
|
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer |
| |
J Isola, S Weitz, T Visakorpi, K Holli, R Shea, N Khabbaz, and OP Kallioniemi |
| |
JCO Jan 1 1993: 36–43.
[Abstract]
[PDF]
|
|
|
Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer |
| |
AL Abner, A Recht, T Eberlein, S Come, L Shulman, D Hayes, JL Connolly, SJ Schnitt, B Silver, and JR Harris |
| |
JCO Jan 1 1993: 44–48.
[Abstract]
[PDF]
|
|
|
A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer |
| |
L Gilbert, LJ Elwood, M Merino, S Masood, R Barnes, SM Steinberg, DF Lazarous, L Pierce, T d'Angelo, and JA Moscow |
| |
JCO Jan 1 1993: 49–58.
[Abstract]
[PDF]
|
|
|
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer |
| |
AH Paterson, TJ Powles, JA Kanis, E McCloskey, J Hanson, and S Ashley |
| |
JCO Jan 1 1993: 59–65.
[Abstract]
[PDF]
|
|
|
Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study |
| |
GA Gellert, RM Maxwell, and BS Siegel |
| |
JCO Jan 1 1993: 66–69.
[Abstract]
[PDF]
|
|
|
Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study |
| |
M Dugan, D Choy, A Ngai, J Sham, P Choi, W Shiu, T Leung, P Teo, U Prasad, and S Lee |
| |
JCO Jan 1 1993: 70–76.
[Abstract]
[PDF]
|
|
|
Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma |
| |
SC Schold, Jr, JE Herndon, PC Burger, EC Halperin, NA Vick, JG Cairncross, DR Macdonald, EJ Dropcho, R Morawetz, and DD Bigner |
| |
JCO Jan 1 1993: 77–83.
[Abstract]
[PDF]
|
|
|
Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents |
| |
DC West, RC Shamberger, RM Macklis, HP Kozakewich, AS Wayne, SG Kreissman, BR Korf, B Lavally, and HE Grier |
| |
JCO Jan 1 1993: 84–90.
[Abstract]
[PDF]
|
|
|
Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study |
| |
DM Green, NE Breslow, JB Beckwith, J Takashima, P Kelalis, and GJ D'Angio |
| |
JCO Jan 1 1993: 91–95.
[Abstract]
[PDF]
|
|
|
Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study |
| |
EC Douglass, M Reynolds, M Finegold, AB Cantor, and A Glicksman |
| |
JCO Jan 1 1993: 96–99.
[Abstract]
[PDF]
|
|
|
Efficacy and toxicity of multiagent chemotherapy and low-dose involved- field radiotherapy in children and adolescents with Hodgkin's disease |
| |
MM Hudson, C Greenwald, E Thompson, J Wilimas, N Marina, D Fairclough, W Kauffman, P Bozeman, PW Mackert, and M Abromowitch |
| |
JCO Jan 1 1993: 100–108.
[Abstract]
[PDF]
|
|
|
Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors |
| |
AL Cheng, IJ Su, YC Chen, TC Lee, and CH Wang |
| |
JCO Jan 1 1993: 109–115.
[Abstract]
[PDF]
|
|
|
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy |
| |
V Gandhi, E Estey, MJ Keating, and W Plunkett |
| |
JCO Jan 1 1993: 116–124.
[Abstract]
[PDF]
|
|
|
Dose-related immunologic effects of levamisole in patients with cancer |
| |
J Janik, WC Kopp, JW Smith, 2d, DL Longo, WG Alvord, WH Sharfman, RG Fenton, M Sznol, RG Steis, and SP Creekmore |
| |
JCO Jan 1 1993: 125–135.
[Abstract]
[PDF]
|
|
|
Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses |
| |
BA Pockaj, SL Topalian, SM Steinberg, DE White, and SA Rosenberg |
| |
JCO Jan 1 1993: 136–147.
[Abstract]
[PDF]
|
|
|
Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial |
| |
S Cascinu, A Fedeli, SL Fedeli, and G Catalano |
| |
JCO Jan 1 1993: 148–151.
[Abstract]
[PDF]
|
|
|
Body-composition changes in patients who gain weight while receiving megestrol acetate |
| |
CL Loprinzi, DJ Schaid, AM Dose, NL Burnham, and MD Jensen |
| |
JCO Jan 1 1993: 152–154.
[Abstract]
[PDF]
|
|
|
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study |
| |
MR Cooper, K Dear, OR McIntyre, H Ozer, J Ellerton, G Canellos, B Bernhardt, D Duggan, D Faragher, and C Schiffer |
| |
JCO Jan 1 1993: 155–160.
[Abstract]
[PDF]
|
|
|
Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study |
| |
RM Bukowski, M Wolfe, HS Levine, DE Crawford, RL Stephens, E Gaynor, and WG Harker |
| |
JCO Jan 1 1993: 161–165.
[Abstract]
[PDF]
|
|
|
Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma |
| |
BE Nelson, AT Rosenfield, and PE Schwartz |
| |
JCO Jan 1 1993: 166–172.
[Abstract]
[PDF]
|
|
|
Ifosfamide, mesna, and nephrotoxicity in children |
| |
R Skinner, IM Sharkey, AD Pearson, and AW Craft |
| |
JCO Jan 1 1993: 173–190.
[Abstract]
[PDF]
|
|
| Timing of radiotherapy in the treatment of early-stage breast cancer |
| B McCormick, CB Begg, L Norton, TJ Yao, and D Kinne |
|
JCO Jan 1 1993: 191–193.
[PDF]
|
|
| In rectal carcinoma, colostomy or no colostomy: is this the question? |
| JA Ajani |
|
JCO Jan 1 1993: 193–194.
[PDF]
|
|
| Use of stereotactic radiosurgery in the treatment of malignant glioma |
| FT Vertosick, Jr |
|
JCO Jan 1 1993: 194–195.
[PDF]
|
|
| Age effects of radiation-associated neurotoxicity in children |
| M Smith and R Simon |
|
JCO Jan 1 1993: 195–196.
[PDF]
|
|
| CPT-11-induced cholinergic effects in cancer patients |
| D Gandia, D Abigerges, JP Armand, G Chabot, L Da Costa, M De Forni, A Mathieu- Boue, and P Herait |
|
JCO Jan 1 1993: 196–197.
[PDF]
|
|
| Ondansetron compatible with sodium acetate |
| AR Hauser, LA Trissel, and JF Martinez |
|
JCO Jan 1 1993: 197.
[PDF]
|
|
